{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:50:01Z","timestamp":1793811001762,"version":"4.6.1"},"reference-count":117,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":275,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20410"],"award-info":[{"award-number":["U20A20410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151220"],"award-info":[{"award-number":["82151220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005356","name":"Zhejiang Shuren University","doi-asserted-by":"publisher","award":["2024R057"],"award-info":[{"award-number":["2024R057"]}],"id":[{"id":"10.13039\/501100005356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.csbj.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:06:24Z","timestamp":1760069184000},"page":"259-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Advances in the structure-based design of protein vaccines for respiratory infectious diseases"],"prefix":"10.34133","volume":"29","author":[{"given":"Xiaotian","family":"Tie","sequence":"first","affiliation":[{"name":"Zhejiang Chinese Medical University, Hangzhou 310053, PR China"},{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[{"name":"Zhejiang Chinese Medical University, Hangzhou 310053, PR China"},{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhejiang Chinese Medical University, Hangzhou 310053, PR China"},{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Weng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keda","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.12.013"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100967"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00619-9"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1669"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq4545"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo4100"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.02.011"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70016","article-title":"Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue","volume":"5","author":"Li Q.","year":"2024","unstructured":"Li Q., Li H., Li Z. and Wang Y.: Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue. MedComm (2020) 2024; 5: e70016.","journal-title":"MedComm (2020)"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00291-2"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.11.006"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00847-5"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70146","article-title":"Intranasal inoculation of cationic crosslinked carbon Dots-Adjuvanted respiratory syncytial virus f subunit vaccine elicits mucosal and systemic humoral and cellular immunity","volume":"6","author":"Lei H.","year":"2025","unstructured":"Lei H., Alu A., Yang J., He C., Shi J., Hong W. et al: Intranasal inoculation of cationic crosslinked carbon Dots-Adjuvanted respiratory syncytial virus f subunit vaccine elicits mucosal and systemic humoral and cellular immunity. MedComm (2020) 2025; 6: e70146.","journal-title":"MedComm (2020)"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042420-113212"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1038\/s41467-024-53937-4","article-title":"Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain","volume":"15","author":"Feng Q.","year":"2024","unstructured":"Feng Q., Cheng K., Zhang L., Wang D., Gao X., Liang J. et al: Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain. Nat Commun 2024; 15: 9581.","journal-title":"Nat Commun"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202000818"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302248","article-title":"Improved humoral immunity and protection against influenza virus infection with a 3d porous biomaterial vaccine","volume":"10","author":"Miwa H.","year":"2023","unstructured":"Miwa H., Antao O.Q., Kelly-Scumpia K.M., Baghdasarian S., Mayer D.P., Shang L. et al: Improved humoral immunity and protection against influenza virus infection with a 3d porous biomaterial vaccine. Adv Sci (Weinh) 2023; 10: e2302248.","journal-title":"Adv Sci (Weinh)"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114142"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.11.001"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2024.12.002","article-title":"Nanocarrier vaccines for respiratory infections","author":"Jiang Y.","year":"2025","unstructured":"Jiang Y., Lei L., Zhao M., Tian Y., Huang Y. and Yang M.: Nanocarrier vaccines for respiratory infections. Trends Mol Med 2025; .","journal-title":"Trends Mol Med"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1038\/s41467-024-50234-y","article-title":"An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models","volume":"15","author":"Leekha A.","year":"2024","unstructured":"Leekha A., Saeedi A., Kumar M., Sefat K., Martinez-Paniagua M., Meng H. et al: An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models. Nat Commun 2024; 15: 6053.","journal-title":"Nat Commun"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202005637","article-title":"SARS-CoV-2 RBD neutralizing antibody induction is enhanced by particulate vaccination","volume":"32","author":"Huang W.C.","year":"2020","unstructured":"Huang W.C., Zhou S., He X., Chiem K., Mabrouk M.T., Nissly R.H. et al: SARS-CoV-2 RBD neutralizing antibody induction is enhanced by particulate vaccination. Adv Mater 2020; 32: e2005637.","journal-title":"Adv Mater"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen J.","year":"2017","unstructured":"Pallesen J., Wang N., Corbett K.S., Wrapp D., Kirchdoerfer R.N., Turner H.L. et al: Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci USA 2017; 114: E7348.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1234914"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9143"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3927"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0305-x"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.03.045"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2024.05.004"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41467-023-36789-2","article-title":"Safety and immunogenicity of a thermostable ID93\u2009+\u2009GLA-SE tuberculosis vaccine candidate in healthy adults","volume":"14","author":"Sagawa Z.K.","year":"2023","unstructured":"Sagawa Z.K., Goman C., Frevol A., Blazevic A., Tennant J., Fisher B. et al: Safety and immunogenicity of a thermostable ID93\u2009+\u2009GLA-SE tuberculosis vaccine candidate in healthy adults. Nat Commun 2023; 14: 1138.","journal-title":"Nat Commun"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101262","article-title":"Spherical nucleic acid vaccine structure markedly influences adaptive immune responses of clinically utilized prostate cancer targets","volume":"10","author":"Teplensky M.H.","year":"2021","unstructured":"Teplensky M.H., Dittmar J.W., Qin L., Wang S., Evangelopoulos M., Zhang B. et al: Spherical nucleic acid vaccine structure markedly influences adaptive immune responses of clinically utilized prostate cancer targets. Adv Health Mater 2021; 10: e2101262.","journal-title":"Adv Health Mater"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01470"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28931-3"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243283"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1118-7"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00127-4"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba6466","article-title":"A respiratory syncytial virus (RSV) f protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain","volume":"5","author":"Swanson K.A.","year":"2020","unstructured":"Swanson K.A., Rainho-Tomko J.N., Williams Z.P., Lanza L., Peredelchuk M., Kishko M. et al: A respiratory syncytial virus (RSV) f protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. Sci Immunol 2020; 5.","journal-title":"Sci Immunol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/s41467-024-46295-8","article-title":"Engineered dityrosine-bonding of the RSV prefusion f protein imparts stability and potency advantages","volume":"15","author":"Gidwani S.V.","year":"2024","unstructured":"Gidwani S.V., Brahmbhatt D., Zomback A., Bassie M., Martinez J., Zhuang J. et al: Engineered dityrosine-bonding of the RSV prefusion f protein imparts stability and potency advantages. Nat Commun 2024; 15: 2202.","journal-title":"Nat Commun"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57659","article-title":"Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens","volume":"9","author":"Ueda G.","year":"2020","unstructured":"Ueda G., Antanasijevic A., Fallas J.A., Sheffler W., Copps J., Ellis D. et al: Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens. Elife 2020; 9.","journal-title":"Elife"},{"key":"e_1_3_4_43_2","article-title":"Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines","author":"Walls A.C.","year":"2021","unstructured":"Walls A.C., Miranda M.C., Pham M.N., Sch\u00e4fer A., Greaney A., Arunachalam P.S. et al: Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. bioRxiv 2021; .","journal-title":"bioRxiv"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301034","article-title":"A mosaic nanoparticle vaccine elicits potent mucosal immune response with significant Cross-Protection activity against multiple SARS-CoV-2 sublineages","volume":"10","author":"Zhang X.","year":"2023","unstructured":"Zhang X., Wu S., Liu J., Chen R., Zhang Y., Lin Y. et al: A mosaic nanoparticle vaccine elicits potent mucosal immune response with significant Cross-Protection activity against multiple SARS-CoV-2 sublineages. Adv Sci 2023; 10: e2301034.","journal-title":"Adv Sci"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136653","article-title":"Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory b cell maturation","volume":"5","author":"Kelly H.G.","year":"2020","unstructured":"Kelly H.G., Tan H.X., Juno J.A., Esterbauer R., Ju Y., Jiang W. et al: Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory b cell maturation. JCI Insight 2020; 5.","journal-title":"JCI Insight"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361323","article-title":"A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza a (H1N1) virus elicits protective immune responses in mice and pigs","volume":"15","author":"Tang P.","year":"2024","unstructured":"Tang P., Cui E., Cheng J., Li B., Tao J., Shi Y. et al: A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza a (H1N1) virus elicits protective immune responses in mice and pigs. Front Immunol 2024; 15: 1361323.","journal-title":"Front Immunol"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1039\/D1NR08460G","article-title":"A self-assembling nanoparticle vaccine targeting the conserved epitope of influenza virus hemagglutinin stem elicits a cross-protective immune response","volume":"14","author":"Qiao Y.","year":"2022","unstructured":"Qiao Y., Li S., Jin S., Pan Y., Shi Y., Kong W. et al: A self-assembling nanoparticle vaccine targeting the conserved epitope of influenza virus hemagglutinin stem elicits a cross-protective immune response. Nanoscale 2022; 14: 3250.","journal-title":"Nanoscale"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138405"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303531","article-title":"Self-Assembled multiepitope nanovaccine provides Long-Lasting Cross-Protection against influenza virus","volume":"13","author":"Nie J.","year":"2024","unstructured":"Nie J., Wang Q., Li C., Zhou Y., Yao X., Xu L. et al: Self-Assembled multiepitope nanovaccine provides Long-Lasting Cross-Protection against influenza virus. Adv Health Mater 2024; 13: e2303531.","journal-title":"Adv Health Mater"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12010037","article-title":"Extraordinary titer and broad Anti-SARS-CoV-2 neutralization induced by stabilized RBD nanoparticles from strain BA.5","volume":"12","author":"Wang Z.","year":"2023","unstructured":"Wang Z., Zhang B., Ou L., Qiu Q., Wang L., Bylund T. et al: Extraordinary titer and broad Anti-SARS-CoV-2 neutralization induced by stabilized RBD nanoparticles from strain BA.5. Vaccines 2023; 12.","journal-title":"Vaccines"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12202"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115948"},{"key":"e_1_3_4_53_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12951-022-01469-8","article-title":"Polymerized porin as a novel delivery platform for coronavirus vaccine","volume":"20","author":"Yang Z.","year":"2022","unstructured":"Yang Z., Hua L., Yang M., Li W., Ren Z., Zheng X. et al: Polymerized porin as a novel delivery platform for coronavirus vaccine. J Nanobiotechnol 2022; 20: 260.","journal-title":"J Nanobiotechnol"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-020-00318-0","article-title":"Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2","volume":"5","author":"Yu F.","year":"2020","unstructured":"Yu F., Xiang R., Deng X., Wang L., Yu Z., Tian S. et al: Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2. Signal Transduct Target Ther 2020; 5: 212.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151969","article-title":"Cross-protective immunity following coronavirus vaccination and coronavirus infection","volume":"131","author":"Dangi T.","year":"2021","unstructured":"Dangi T., Palacio N., Sanchez S., Park M., Class J., Visvabharathy L. et al: Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest 2021; 131.","journal-title":"J Clin Invest"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2607-z"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101621","article-title":"Functionalizing ferritin nanoparticles for vaccine development","volume":"13","author":"Rodrigues M.Q.","year":"2021","unstructured":"Rodrigues M.Q., Alves P.M. and Rold\u00e3o A.: Functionalizing ferritin nanoparticles for vaccine development. Pharmaceutics 2021; 13.","journal-title":"Pharmaceutics"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.04.078"},{"key":"e_1_3_4_59_2","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1038\/s41467-024-52908-z","article-title":"Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate","volume":"15","author":"Fu D.","year":"2024","unstructured":"Fu D., Wang W., Zhang Y., Zhang F., Yang P., Yang C. et al: Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate. Nat Commun 2024; 15: 8601.","journal-title":"Nat Commun"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00192"},{"key":"e_1_3_4_61_2","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma X.","year":"2020","unstructured":"Ma X., Zou F., Yu F., Li R., Yuan Y., Zhang Y. et al: Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 2020; 53. 1315-30.e9..","journal-title":"Immunity"},{"key":"e_1_3_4_62_2","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050717","article-title":"A SARS-CoV-2 spike ferritin nanoparticle vaccine is protective and promotes a strong immunological response in the cynomolgus macaque coronavirus disease 2019 (COVID-19) model","volume":"10","author":"Johnston S.C.","year":"2022","unstructured":"Johnston S.C., Ricks K.M., Lakhal-Naouar I., Jay A., Subra C., Raymond J.L. et al: A SARS-CoV-2 spike ferritin nanoparticle vaccine is protective and promotes a strong immunological response in the cynomolgus macaque coronavirus disease 2019 (COVID-19) model. Vaccines 2022; 10.","journal-title":"Vaccines"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01660-8"},{"key":"e_1_3_4_64_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1215323","article-title":"Immunogenicity and protective efficacy of an RSV g S177Q central conserved domain nanoparticle vaccine","volume":"14","author":"Bergeron H.C.","year":"2023","unstructured":"Bergeron H.C., Murray J., Juarez M.G., Nangle S.J., DuBois R.M. and Tripp R.A.: Immunogenicity and protective efficacy of an RSV g S177Q central conserved domain nanoparticle vaccine. Front Immunol 2023; 14: 1215323.","journal-title":"Front Immunol"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8818"},{"key":"e_1_3_4_66_2","article-title":"Distinct antibody and memory b cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination","volume":"6","author":"Goel R.R.","year":"2021","unstructured":"Goel R.R., Apostolidis S.A., Painter M.M., Mathew D., Pattekar A., Kuthuru O. et al: Distinct antibody and memory b cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination. Sci Immunol 2021; 6.","journal-title":"Sci Immunol"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03530-2"},{"key":"e_1_3_4_68_2","article-title":"Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates","volume":"7","author":"He L.","year":"2021","unstructured":"He L., Lin X., Wang Y., Abraham C., Sou C., Ngo T. et al: Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates. Sci Adv 2021; 7.","journal-title":"Sci Adv"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c08379"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03365-x"},{"key":"e_1_3_4_71_2","article-title":"Self-Assembling nanoparticle hemagglutinin influenza vaccines induce high antibody response","volume":"25","author":"Ren H.","year":"2024","unstructured":"Ren H., Zhang B., Zhang X., Wang T., Hou X., Lan X. et al: Self-Assembling nanoparticle hemagglutinin influenza vaccines induce high antibody response. Int J Mol Sci 2024; 25.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_72_2","doi-asserted-by":"crossref","first-page":"9884","DOI":"10.1038\/s41467-024-54289-9","article-title":"A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naive non-human primates","volume":"15","author":"Vijayan A.","year":"2024","unstructured":"Vijayan A., Vogels R., Groppo R., Jin Y., Khan S., Van Kampen M. et al: A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naive non-human primates. Nat Commun 2024; 15: 9884.","journal-title":"Nat Commun"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.043"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.046"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30222-w"},{"key":"e_1_3_4_76_2","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41467-023-41661-4","article-title":"Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera","volume":"14","author":"Hutchinson G.B.","year":"2023","unstructured":"Hutchinson G.B., Abiona O.M., Ziwawo C.T., Werner A.P., Ellis D., Tsybovsky Y. et al: Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera. Nat Commun 2023; 14: 6195.","journal-title":"Nat Commun"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c06526"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c01829"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.045"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.12.044"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.11.047"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.11.009"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00200-0"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.011"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl3381"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.015"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj5305"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00809-2"},{"key":"e_1_3_4_91_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10875-010-9490-6","article-title":"H5N1 influenza vaccine formulated with AS03 a induces strong cross-reactive and polyfunctional CD4 T-cell responses","volume":"31","author":"Moris P.","year":"2011","unstructured":"Moris P., van der Most R., Leroux-Roels I., Clement F., Dram\u00e9 M., Hanon E. et al: H5N1 influenza vaccine formulated with AS03 a induces strong cross-reactive and polyfunctional CD4 T-cell responses. J Clin Immunol 2011; 31: 443.","journal-title":"J Clin Immunol"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00764-7"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-023-12520-5"},{"key":"e_1_3_4_94_2","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202301801","article-title":"ISCOMs\/MPLA-Adjuvanted SDAD protein nanoparticles induce improved mucosal immune responses and Cross-Protection in mice","volume":"19","author":"Zhu W.","year":"2023","unstructured":"Zhu W., Park J., Pho T., Wei L., Dong C., Kim J. et al: ISCOMs\/MPLA-Adjuvanted SDAD protein nanoparticles induce improved mucosal immune responses and Cross-Protection in mice. Small 2023; 19: e2301801.","journal-title":"Small"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024671"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00455-9"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c03509"},{"key":"e_1_3_4_98_2","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-022-31709-2","article-title":"CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns","volume":"13","author":"van Haren S.D.","year":"2022","unstructured":"van Haren S.D., Pedersen G.K., Kumar A., Ruckwardt T.J., Moin S., Moore I.N. et al: CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns. Nat Commun 2022; 13: 4234.","journal-title":"Nat Commun"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj6538"},{"key":"e_1_3_4_100_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41467-025-56369-w","article-title":"De novo design of protein minibinder agonists of TLR3","volume":"16","author":"Adams C.S.","year":"2025","unstructured":"Adams C.S., Kim H., Burtner A.E., Lee D.S., Dobbins C., Criswell C. et al: De novo design of protein minibinder agonists of TLR3. Nat Commun 2025; 16: 1234.","journal-title":"Nat Commun"},{"key":"e_1_3_4_101_2","article-title":"Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission","author":"Jennewein M.F.","year":"2025","unstructured":"Jennewein M.F., Schultz M.D., Beaver S., Battisti P., Bakken J., Hanson D. et al: Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission. Mol Ther 2025; .","journal-title":"Mol Ther"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1655"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114173"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2024.02.041"},{"key":"e_1_3_4_105_2","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202412294","article-title":"Spatial engineering of heterotypic antigens on a DNA framework for the preparation of mosaic nanoparticle vaccines with enhanced immune activation against SARS-CoV-2 variants","volume":"63","author":"Zhang J.","year":"2024","unstructured":"Zhang J., Xu Y., Chen M., Wang S., Lin G., Huang Y. et al: Spatial engineering of heterotypic antigens on a DNA framework for the preparation of mosaic nanoparticle vaccines with enhanced immune activation against SARS-CoV-2 variants. Angew Chem Int Ed Engl 2024; 63: e202412294.","journal-title":"Angew Chem Int Ed Engl"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c07741"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100780"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01776-2"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.1c00080"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c04188"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1039\/D2CS00848C"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101245"},{"key":"e_1_3_4_114_2","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202402059","article-title":"Opportunities and challenges for nanomaterials as vaccine adjuvants","author":"Li Z.","year":"2025","unstructured":"Li Z., Chen P., Qu A., Sun M., Xu L., Xu C. et al: Opportunities and challenges for nanomaterials as vaccine adjuvants. Small Methods 2025; : e2402059.","journal-title":"Small Methods"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01557-7"},{"key":"e_1_3_4_116_2","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202002750","article-title":"Template-Mediated assembly of DNA into microcapsules for immunological modulation","volume":"16","author":"Qu Y.","year":"2020","unstructured":"Qu Y., Ju Y., Cortez-Jugo C., Lin Z., Li S., Zhou J. et al: Template-Mediated assembly of DNA into microcapsules for immunological modulation. Small 2020; 16: e2002750.","journal-title":"Small"},{"key":"e_1_3_4_117_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202310108","article-title":"Picrasidine s induces cGAS-Mediated cellular immune response as a novel vaccine adjuvant","volume":"11","author":"Ding X.","year":"2024","unstructured":"Ding X., Sun M., Guo F., Qian X., Yuan H., Lou W. et al: Picrasidine s induces cGAS-Mediated cellular immune response as a novel vaccine adjuvant. Adv Sci 2024; 11: e2310108.","journal-title":"Adv Sci"},{"key":"e_1_3_4_118_2","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002990","article-title":"Ionic-Liquid-Based safe adjuvants","volume":"32","author":"Ukidve A.","year":"2020","unstructured":"Ukidve A., Cu K., Goetz M., Angsantikul P., Curreri A., Tanner E.E.L. et al: Ionic-Liquid-Based safe adjuvants. Adv Mater 2020; 32: e2002990.","journal-title":"Adv Mater"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702500409X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702500409X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.10.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:24:30Z","timestamp":1778012670000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.10.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":117,"alternative-id":["10.1016\/j.csbj.2025.10.008"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.10.008","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the structure-based design of protein vaccines for respiratory infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}